Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | NBIX Neurocrine Biosciences, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $148.49 -2.2% | $15.37 +0.0% |
| StockIQ Score | 61C+ Moderate Risk: Medium | 35F Weak Risk: High |
| Technical | 26F | 13F |
| Fundamental | 76B+ | 35F |
| Growth | 82A- | 50C- |
| Fair Value | 62C+ | 38F |
| News | 92A+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
NBIX has higher investor, fundamental, growth, and valuation scores than AAPG (61 vs 35, 76 vs 35, 82 vs 50, 62 vs 38). Its technical score is also higher (26 vs 13). Overall NBIX is rated MODERATE while AAPG is rated WEAK.